Gause A - Search Results

1

Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease.

Trümper L, Jung W, Dahl G, Diehl V, Gause A, Pfreundschuh M. Trümper L, et al. Among authors: gause a. Ann Oncol. 1994;5 Suppl 1:93-6. doi: 10.1093/annonc/5.suppl_1.s93. Ann Oncol. 1994. PMID: 8172827 Clinical Trial.

2

Single cell PCR for the analysis of Hodgkin's disease: four years later.

Küpper M, Loftin U, von Bonin F, Gause A, Pfreundschuh M, Daus H, Trümper L. Küpper M, et al. Among authors: gause a. Ann Oncol. 1996;7 Suppl 4:35-9. doi: 10.1093/annonc/7.suppl_4.s35. Ann Oncol. 1996. PMID: 8836407 Review.

3

The clinical significance of cytokines and soluble forms of membrane-derived activation antigens in the serum of patients with Hodgkin's disease.

Gause A, Jung W, Keymis S, Schobert I, Scholz R, Schmits R, Diehl V, Pohl C, Hasenclever D, Pfreundschuh M. Gause A, et al. Leuk Lymphoma. 1992 Aug;7(5-6):439-47. doi: 10.3109/10428199209049800. Leuk Lymphoma. 1992. PMID: 1283546

4

Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma.

Gause A, Jung W, Schmits R, Tschiersch A, Scholz R, Pohl C, Hasenclever D, Diehl V, Pfreundschuh M. Gause A, et al. Ann Oncol. 1992 Sep;3 Suppl 4:49-52. doi: 10.1093/annonc/3.suppl_4.s49. Ann Oncol. 1992. PMID: 1333270

5

Increased levels of circulating cytokines in patients with untreated Hodgkin's disease.

Gause A, Keymis S, Scholz R, Schobert I, Jung W, Diehl V, Pohl C, Pfreundschuh M. Gause A, et al. Lymphokine Cytokine Res. 1992 Apr;11(2):109-13. Lymphokine Cytokine Res. 1992. PMID: 1581417

6

The clinical significance of serum CD8 antigen levels in adult patients with Hodgkin's disease.

Gause A, Verpoort K, Roschansky V, Tschiersch A, Hasenclever D, Schmits R, Diehl V, Brosteanu O, Pfreundschuh M. Gause A, et al. Ann Oncol. 1991 Sep;2(8):579-83. doi: 10.1093/oxfordjournals.annonc.a058024. Ann Oncol. 1991. PMID: 1724380 Free article. Clinical Trial.

7

Increased levels of circulating interleukin-6 in patients with Hodgkin's disease.

Gause A, Scholz R, Klein S, Jung W, Diehl V, Tesch H, Hasenclever D, Pfreundschuh M. Gause A, et al. Hematol Oncol. 1991 Nov-Dec;9(6):307-13. doi: 10.1002/hon.2900090605. Hematol Oncol. 1991. PMID: 1748397

8

Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.

Gause A, Pohl C, Tschiersch A, Da Costa L, Jung W, Diehl V, Hasenclever D, Pfreundschuh M. Gause A, et al. Blood. 1991 May 1;77(9):1983-8. Blood. 1991. PMID: 1850308 Free article.

9

Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma.

Gause A, Roschansky V, Tschiersch A, Smith K, Hasenclever D, Schmits R, Diehl V, Pfreundschuh M. Gause A, et al. Ann Oncol. 1991 Feb;2 Suppl 2:43-7. doi: 10.1007/978-1-4899-7305-4_7. Ann Oncol. 1991. PMID: 2049320 Free article. Clinical Trial.

10

Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources.

Jung W, Krueger S, Renner C, Gause A, Sahin U, Trümper L, Pfreundschuh M. Jung W, et al. Among authors: gause a. Mol Immunol. 1994 Dec;31(17):1329-34. doi: 10.1016/0161-5890(94)90051-5. Mol Immunol. 1994. PMID: 7527901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters